A Long-Term Observational Study of Patients With Fucosidosis
NCT07615400 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 57
Last updated 2026-05-29
Summary
The purpose of this observational research study is to learn more about the natural history of fucosidosis, its symptoms, and how it develops over time.
This study intends to collect information from participants diagnosed with fucosidosis; however, this study does not include any medication or treatment other than the usual medical care provided to study participants.
The information collected in this study will be used to help understand the disease characteristics of fucosidosis; with this information potentially being able to help design future studies and treatments for this disease.
There is currently no approved treatment for patients with fucosidosis.
The study consists of 2 parts: a) Part A - retrospective data collection, and b) Part B - prospective data collection.
Conditions
- Fucosidosis
Sponsors & Collaborators
-
JCR Pharmaceuticals Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Karolina M Stepien, MD · Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-25
- Primary Completion
- 2031-01-31
- Completion
- 2031-01-31
Countries
- United States
- India
- Netherlands
- Tunisia
- Turkey (Türkiye)
- United Kingdom
Study Locations
More Related Trials
-
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
NCT04617561 ·Status: UNKNOWN ·Phase: PHASE4
-
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
NCT06174402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
NCT01755507 ·Status: COMPLETED ·Phase: PHASE2
-
Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
NCT02916641 ·Status: UNKNOWN ·Phase: PHASE3
-
Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis
NCT01141296 ·Status: WITHDRAWN ·Phase: PHASE2
-
Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.
NCT02868164 ·Status: WITHDRAWN ·Phase: NA
-
A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
NCT06591455 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Use of Fenofibrate for Primary Biliary Cirrhosis
NCT00575042 ·Status: COMPLETED ·Phase: PHASE2
-
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
NCT02823366 ·Status: UNKNOWN ·Phase: PHASE3
-
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
NCT04618575 ·Status: UNKNOWN ·Phase: PHASE4
-
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.
NCT02721264 ·Status: UNKNOWN ·Phase: NA
-
Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
NCT00746486 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
NCT07282353 ·Status: RECRUITING ·Phase: PHASE3
-
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
NCT05751967 ·Status: RECRUITING ·Phase: PHASE3
-
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
NCT00004842 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Extension Study for Subjects Previously Enrolled in Triheptanoin Studies
NCT02214160 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
NCT06165341 ·Status: RECRUITING ·Phase: PHASE3
-
Pilot Study of FFP104 Dose Escalation in PBC Subjects
NCT02193360 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
NCT02916290 ·Status: UNKNOWN ·Phase: PHASE3
-
Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
NCT06365424 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia
NCT06610760 ·Status: RECRUITING ·Phase: PHASE4
-
Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis
NCT00470171 ·Status: COMPLETED ·Phase: PHASE2
-
Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
NCT00004748 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease
NCT02303314 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
NCT07104201 ·Status: RECRUITING ·Phase: EARLY_PHASE1